Embecta Corp
Suletud
SektorTervishoid
3.1 -0.64
Ülevaade
Aktsiahinna muutus
24h
Min
3.04
Max
3.22
Sissetulek | -48M -4.1M |
|---|---|
Müük | -39M 222M |
P/E Sektori keskmine | 1.775 49.052 |
Aktsiakasum | 0.27 |
Dividenditootlus | 17.75 |
Kasumimarginaal | -1.849 |
Töötajad | 1,850 |
EBITDA | -40M 56M |
Soovitused | Müü |
|---|---|
12 kuu keskmine prognoos | +27.8% upside |
Dividenditootlus Sektori keskmine | 17.75% 2.36% |
|---|---|
Järgmine tulemuste avaldamine | 7. aug 2026 |
Järgmine dividendimakse kuupäev | 14. sept 2026 |
Järgmine aktsia dividendi kuupäev (ex-date) | 28. aug 2026 |
Turukapital | -349M 199M |
|---|---|
Eelmine avamishind | 3.74 |
Eelmine sulgemishind | 3.1 |
Uudiste sentiment
By Acuity
63%
37%
296 / 342 Pingereas Healthcare
Embecta Corp Graafik
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
Ettevõttest Embecta Corp
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
